title: [Interview with Professor Jürgen Rockstroh, director of the Bonn University Clinic. Atazanavir in general practice].
authors.forename: Jürgen
authors.initials: J
authors.lastname: Rockstroh
mesh_terms: D000069446:Atazanavir Sulfate; D003692:Delayed-Action Preparations; D004334:Drug Administration Schedule; D017277:Drug Approval; D004359:Drug Therapy, Combination; D015658:HIV Infections / Q000188:drug therapy*; D017320:HIV Protease Inhibitors / Q000008:administration & dosage* / Q000009:adverse effects; D006801:Humans; D009842:Oligopeptides / Q000008:administration & dosage* / Q000009:adverse effects; D011725:Pyridines / Q000008:administration & dosage* / Q000009:adverse effects
chemical_list: D003692:Delayed-Action Preparations; D017320:HIV Protease Inhibitors; D009842:Oligopeptides; D011725:Pyridines; D000069446:Atazanavir Sulfate
vernacular_title: Interview mit Professor Jürgen Rockstroh, Oberarzt am Universitätsklinikum Bonn. Atazanavir in der Praxis.